Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-08-28

Clinical Trial Update: Comparison of Volinanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance Difficulties [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Volinanserin and Lormetazepam for insomnia with sleep maintenance difficulties was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lormetazepam (lormetazepam)
  • Volinanserin (volinanserin)

Snippet

Sponsor: Sanofi | Conditions: Sleep Initiation and Maintenance Disorders | Phase 3 | Status: TERMINATED